Full Text
Full text is available in PDF
Nephro-Urology Monthly
Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer
Author(s):
1Department of Urology, Kantonsspital Winterthur, [email protected], Switzerland
*Corresponding Author: Kantonsspital Winterthur, Department of Urology, Brauerstr 15, 8401 Winterthur, [email protected], Switzerland. Tel: +52-2664171. Fax: +52-26645003. Email: [email protected]
Published online:Dec 19, 2011
Article type:Review Article
Received:Jul 05, 2011
Accepted:Jul 29, 2011
How to Cite:Horstmann M. Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer. Nephro-Urol Mon. 2011;4(1):. doi: https://doi.org/10.5812/kowsar.22517006.1841
Abstract
Bladder cancer represents a major health care burden in many societies. Currently, cystoscopy and urinary cytology are the gold standard in bladder cancer detection. To further improve detection and/or to reduce expensive and invasive cystoscopies, highly sensitive and specific urine-based tumour markers are requested. Until now, several urine-based tumour markers for the detection and surveillance of bladder cancer have been developed and are commercially available. Others are under research. This paper gives an overview of the currently commercially available urine-based tumour makers for bladder cancer. Information is based on a non-systematic PubMed literature search. All markers were at least in some studies superior to urinary cytology; however, none of them can be considered sensitive and specific enough alone to substantially reduce the necessity of cystoscopies. The recommended use of urine-based tumour markers therefore remains in adjunction to cystoscopy and for some of them in individual screening situations of patients at high risk.
- Implication for health policy/practice/research/medical education:
Urine-based tumour markers might become a helpful tool in early detection of bladder cancer. This review is adressed to health professionals dealing with bladder cancer patients and patients at risk.
- Please cite this paper as:
Horstmann M. Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer. Nephro-Urol Mon.2012;4(1): 345-9.DOI: 10.5812/kowsar.22517006.1841
Copyright © 2012, Kowsar M.P.Co. All rights reserved.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Jun
2009
Can use the NMP22 BladderChek Decrease the Frequency of Cystoscopy in the Follow up of Patients with Bladder Carcinoma ?
Adel Allam,
Badawi Hathout,
Salah Alnusif
Allam A, Hathout B, Alnusif S. Can use the NMP22 BladderChek Decrease the Frequency of Cystoscopy in the Follow up of Patients with Bladder Carcinoma ?. Nephro-Urol Mon. 2009;1(1):. doi:
24
Apr
2016
Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression
Zahra Malek-Hosseini,
Abdolaziz Khezri,
Zahra Amirghofran
Malek-Hosseini Z, Khezri A, Amirghofran Z. Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression. Int J Cancer Manag. 2016;9(2):e4086. doi: https://doi.org/10.17795/ijcp-4086
31
May
2017
Urinary Tract Infection in Children: Diagnostic and Prognostic Utility of Biomarkers
Samuel N. Uwaezuoke
Uwaezuoke SN. Urinary Tract Infection in Children: Diagnostic and Prognostic Utility of Biomarkers. J Compr Ped. 2017;8(2):e59248. doi: https://doi.org/10.5812/compreped.59248
16
Jul
2023
Bladder Metastatic Breast Cancer Presenting Initially with Lower Urinary Tract Symptoms: A Rare Case Report
Maryam Emami,
Maryam Abolhasani,
Yasin Zakeri,
Behnam Shakiba,
Amir Mohammad Arefpour,
Seyed Morteza Bagheri
,et al.Emami M, Abolhasani M, Zakeri Y, Shakiba B, Arefpour AM, et al. Bladder Metastatic Breast Cancer Presenting Initially with Lower Urinary Tract Symptoms: A Rare Case Report. Nephro-Urol Mon. 2023;15(2):e136211. doi: https://doi.org/10.5812/numonthly-136211
15
Mar
2025
Prognostic Factors for Intravesical Recurrence in NMIBC: Evaluating the Role of Pyuria, Bacteriuria, and Comorbidities
Solmaz Ohadian Moghadam,
Iman Menbary Oskouie,
Erfan Amini,
Seyed Ali Momeni,
Mojtaba Haddad,
Amir Kasaeian
,et al.Ohadian Moghadam S, Menbary Oskouie I, Amini E, Momeni SA, Haddad M, et al. Prognostic Factors for Intravesical Recurrence in NMIBC: Evaluating the Role of Pyuria, Bacteriuria, and Comorbidities. Int J Cancer Manag. 2025;18(1):e151782. doi: https://doi.org/10.5812/ijcm-151782
Download PDF826.73 KB
Crossmark
Checking
Comments
Number of Comments:0Cited by
- Scopus by DOI: 8
Last Update: 2 weeks ago
- Scopus by Title: 8
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Related Articles